Showing results (281-290 of 382) with videos related to
Sort By:
Pageof 39
The Cochrane Database of Systematic Reviews|October 18, 2000
Antimalarials for treating rheumatoid arthritisM E Suarez-Almazor, E Belseck, B Shea, et al.The Cochrane Database of Systematic Reviews|June 19, 2001
Transcutaneous electrical nerve stimulation (TENS) for chronic low back painS Milne, V Welch, L Brosseau, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical PracticeMichael B Shea, Mark Stewart, Hugo Van Dyke, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Prazosin for Raynaud's phenomenon in progressive systemic sclerosisJ Pope, D Fenlon, A Thompson, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosisJ Pope, D Fenlon, A Thompson, et al.The Journal of Rheumatology|January 26, 1999
The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trialsZ Ortiz, B Shea, M Garcia Dieguez, et al.The Journal of Rheumatology|January 26, 1999
Responsiveness of endpoints in osteoporosis clinical trials--an updateA Cranney, V Welch, P Tugwell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2013
Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvalsMichael B Shea, Samantha A Roberts, Jessica C Walrath, et al.Journal of Alzheimer'S Disease : JAD|March 12, 2016
Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label StudyRuth Remington, Cynthia Bechtel, David Larsen, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Bisphosphonates for steroid induced osteoporosisJ Homik, A Cranney, B Shea, et al.Pageof 39